Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data.
Journal: Clinical pharmacology and therapeutics
Published: October 06, 2025
Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration.
Journal: Clinical pharmacology and therapeutics
Published: October 04, 2024
A New Quantitative Gait Analysis Method Based on Oscillatory Mechanical Energies Measured near Body Center of Mass.
Journal: Sensors (Basel, Switzerland)
Published: October 09, 2022
Showing 1-4 of 4
Last Updated: 09/26/2026